title: [Timoptol in the after-care following argon laser trabeculoplasty].
abstract: In 17% of the author's 205 patients treated by argon laser trabeculoplasty, Timoptol was the sole local antiglaucoma medication given postoperatively. These patients benefited from a particularly advantageous situation. Intraocular pressure was once again reliably regulated. In addition, there were no visual disturbances, e.g., as caused by miotics. Local and general tolerance are excellent; the level of patient discomfort is very low, as the drops are only applied once or twice a day; and, finally, the patient remains in ophthalmological care. Postoperative treatment with Timoptol has also proved highly successful in another group of patients, i.e., glaucoma patients in whom an argon laser trabeculoplasty was performed prior to cataract extraction. In these patients the subsequent cataract extraction is greatly facilitated because the pupil can be readily dilated.
mesh_terms: D003131:Combined Modality Therapy; D005901:Glaucoma / Q000188:drug therapy / Q000601:surgery*; D005902:Glaucoma, Open-Angle / Q000188:drug therapy / Q000601:surgery; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D053685:Laser Therapy; D011183:Postoperative Complications / Q000188:drug therapy*; D013999:Timolol / Q000627:therapeutic use*; D014129:Trabecular Meshwork / Q000601:surgery*
chemical_list: D013999:Timolol
vernacular_title: Timoptol in der Nachbehandlung nach Argon-Laser-Trabekuloplastik.